Mobileye (MBLY) Q2 2026 earnings review
Flat Sales, but a Tax Law Bails Out the Bottom Line
Mobileye's top line stalled out at $508 million (flat YoY) in Q2 2026, breaking the 27% growth momentum seen in Q1. However, the bottom line stole the show due to an external lifeline. The newly enacted Israeli R&D Law triggered a massive $93 million retroactive non-GAAP benefit, artificially inflating Adjusted Operating Income by 46% to $155 million. Look past this regulatory windfall, and the core operational engine faces friction: Average System Prices (ASP) are bleeding down to $48.50, and adjusted gross margins compressed by 303 basis points. While a high-volume Stellantis win and robotaxi progress offer long-term hope, the immediate earnings quality is distorted by one-time tax relief.
🐂 Bull Case
The Israeli R&D Law effectively raises Mobileye's margin baseline permanently. The company raised its FY26 Adjusted Operating Income midpoint by an enormous 88%, providing a massive cushion for future R&D investments.
Adding a Cloud-Enhanced ADAS program with Stellantis doubles the base ADAS profitability per unit. This proves Mobileye can still command premium pricing on advanced features despite broader industry pricing pressure.
🐻 Bear Case
Stripping away the tax benefit, operational profitability is weakening. Adjusted Gross Margin dropped to 66% from 69% last year, driven by a higher mix of lower-priced China OEM shipments and lower-margin SuperVision hardware.
While net income optically surged, actual cash generated from operations in H1 2026 fell 35% YoY to $210 million from $322 million. Working capital is consuming cash while accounting benefits prop up the P&L.
⚖️ Verdict: ⚪
Neutral. The core business volume remains stable at ~10 million units, but the underlying mix is shifting toward lower margins. The massive guidance raise is an accounting win, not an operational acceleration.
Key Themes
The R&D Law Margin Illusion
The most significant driver of Q2 earnings was entirely external. Israel's newly enacted R&D Law (offsetting OECD minimum tax rules) allowed Mobileye to recognize a $93 million non-GAAP offset to Q2 R&D expenses, covering the entire first half of 2026. This fundamentally and permanently alters the company's cost structure, baking $180-$200 million of annual savings into the FY26 outlook.
ASP Bleed from China Export Mix
Average System Price (ASP) continues a steady, decelerating trend, dropping sequentially from $51.70 in 25Q3 to $48.50 in 26Q2. Management directly attributes this to higher-than-expected volumes from China OEMs, which carry a structurally lower price tag. Volume alone cannot mask a degrading pricing mix.
Gross Margin Compression
Management touts robust profitability, but this contradicts the underlying cost of goods sold. Adjusted Gross Margin dropped a severe 303 basis points YoY to 66%. This is a direct consequence of the China volume shift combined with a higher portion of hardware-heavy SuperVision revenue. Mobileye is selling more complex systems but keeping less of the premium.
Stellantis Cloud-Enhanced ADAS Win
A crucial bright spot for future organic margin recovery is the newly announced Cloud-Enhanced ADAS design win with Stellantis. Management explicitly noted that gross profit per unit for this program is roughly double their current base ADAS profitability. This proves the upgrade cycle thesis remains intact among legacy Western automakers.
Robotaxi and Mobility-as-a-Service (MaaS) Commercialization
The timeline for true physical AI innovation is accelerating. Volkswagen's MOIA just began public user testing in Hamburg with safety drivers using Mobileye's self-driving system. Furthermore, Mobileye is leveraging its Moovit acquisition to aggressively expand into vertically-integrated fleet logistics and rider apps, signaling a strategic pivot from pure hardware/software supplier to full MaaS operator.
Operating Cash Flow Decoupling
A significant red flag emerges when comparing the income statement to the cash flow statement. While H1 2026 Adjusted Net Income surged 52% to $251 million, Net Cash Provided by Operating Activities fell 35% to $210 million (down from $322 million in H1 2025). This was driven primarily by an $82 million negative swing in trade accounts receivable.
Macro and Geopolitical Overhang
The massive $3.8 billion goodwill impairment charge taken earlier in the year still looms over the balance sheet. Management continues to cite macroeconomic conditions and global political uncertainty—particularly surrounding tariffs and the volatile regulatory environment in China and Europe—as primary external risks to sustained growth.
Other KPIs
Reversing. Down drastically from $322 million in H1 2025. This contraction exposes the difference between statutory tax benefits boosting paper profits versus actual cash being deposited in the bank.
Stable. Up slightly from 9.7 million a year ago (+3%), but sequentially decelerating from the 10.8 million inventory restocking burst seen in Q1 2026. The volume floor appears solid, but growth requires the advanced product pipeline to activate.
Decelerating. Calculated as $210M operating cash flow minus $51M in CapEx. This is significantly weaker than the $294 million generated in the same period last year, reducing the immediate excess capital available to fund their ambitious robotaxi infrastructure.
Guidance
Stable. The midpoint of $1,995 million implies a mild 4% to 7% YoY growth rate. It is a meager $20 million bump from prior guidance, entirely attributable to the Q1 outperformance, signaling that management expects H2 2026 to remain effectively flat.
Accelerating. The 88% surge in the midpoint guidance (up from $185-$235 million) looks spectacular on paper. However, it is fundamentally driven by the $180-$200 million full-year expectation from the Israeli R&D Law incentive grant, not a sudden surge in underlying operational leverage.
Stable. A slight 4% improvement at the midpoint compared to previous guidance. The catastrophic optics of a $4+ billion loss are entirely tied to the non-cash Q1 goodwill impairment, but it highlights the immense risk premium investors are currently assigning to the business.
Key Questions
Organic Operational Leverage
If we strip out the $180-$200 million R&D tax benefit for FY26, implied underlying Adjusted Operating Income is roughly flat to down YoY. When do you expect true operational leverage to return to the P&L?
China Mix and ASP Floor
With ASP declining for three consecutive quarters due to China OEM export volumes, where do you see the floor for ASP before high-content SuperVision and Surround ADAS programs bend the curve back upward?
Working Capital Friction
Operating cash flow dropped significantly in H1 due to swelling accounts receivable. Are you offering extended payment terms to secure volume, particularly in China, or is this merely a timing issue?
Mobility-as-a-Service Ambitions
You highlighted engagements with vendors for fleet logistics and vehicle upfitting. Is Mobileye pivoting toward a more capital-intensive, vertically integrated operator model, and how will that impact your future OpEx and CapEx profiles?